Johnson Pharmacare Ltd Appoints Nand Kishore Ray and Dheeraj Kumar as New Directors

Johnson Pharmacare Ltd Appoints Nand Kishore Ray and Dheeraj Kumar as New Directors

Johnson Pharmacare Ltd Appoints Nand Kishore Ray and Dheeraj Kumar as New Directors​

Johnson Pharmacare Ltd announced that its Board of Directors held a meeting on April 17, 2026, approving the appointment of two new individuals to key directorial roles. The appointments include Mr. Nand Kishore Ray as an Additional (Non-Executive & Non-Independent Director), and Mr. Dheeraj Kumar as an Additional (Executive Director).

Mr. Nand Kishore Ray was appointed as the Additional Non-Executive & Non-Independent Director effective April 17, 2026. Mr. Ray, whose father is Mr. Kalewar Ray, was born on January 1, 1956, and holds a graduate qualification. His Permanent Account Number (PAN) is HRGPR4939P.

Simultaneously, Mr. Dheeraj Kumar was appointed as the Additional Executive Director, also effective April 17, 2026. Mr. Kumar, son of Nandkishor Ray, was born on January 1, 2005, and is also a graduate. His PAN is QCRPK2905K.

The board’s official records provide a brief overview of the profiles of the newly appointed directors:

Profile Details of Appointed Directors​

Director NameDINRoleFather's NameDate of BirthEducation QualificationPAN
Mr. Nand Kishore Ray11626638Additional (Non-Executive & Non-Independent Director)Mr. Kalewar Ray01/01/1956GraduateHRGPR4939P
Mr. Dheeraj Kumar11666616Additional (Executive Director)Mr. Nand Kishor Ray01.01.2005GraduateQCRPK2905K

Stock Price Movement​

Johnson Pharmacare Ltd shares settled at ₹0.62 today, posting a strong gain of 6.90% by the close. Throughout the session, the stock traded within a noticeable range, hitting a low of ₹0.57 and peaking at ₹0.65.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top